Strategic partnerships are often the fastest route to creating value in life sciences. Whether securing development expertise, non-dilutive funding, licensing agreements or commercial collaborations, success depends on being recognised as a partner of choice.
Our team brings first-hand experience of pharmaceutical partnering, business development and venture capital. As AstraZeneca’s Head of Partnering Communications, Katja supported the company’s rise from 11th to 3rd place in the BCG Partnering League Tables between 2011 and 2013, while helping communicate some of the industry’s most significant licensing, collaboration and acquisition transactions.
We help companies articulate a compelling partnering proposition, increase visibility among potential partners and ensure management teams are equipped to communicate effectively throughout the deal-making process. From messaging and partner-facing materials to conference visibility and executive profiling, we help companies build the awareness, credibility and relationships needed to support successful partnerships.
Our work supporting AstraZeneca’s partnering activities contributed to multiple Scrip Awards, including Best Partnership Alliance (2010–2014), Best Licensing Deal (2013 and 2014) and Management Team of the Year (2014).
Services
- Partnering strategy & communications counsel
- Partnering proposition development
- Business development messaging
- Partnering presentations
- Technology & product factsheets
- Presentation & pitch training
- Executive visibility programmes
- Speaker platforms & conference engagement
- Trade media relations
- Thought leadership content
- Webinars & virtual events
- Business development introductions
